Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases
11:06am, Friday, 23'rd May 2025
BAYRY's Eylea 8 mg gets CHMP nod in EU, promising 6-month dosing for nAMD and DME with strong 3-year efficacy and safety data.
Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals
02:58am, Friday, 23'rd May 2025
German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge over Roche'
Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development
10:58am, Thursday, 22'nd May 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the launch of its Imaging Core Lab Services under the brand name Centafore. With over 25 years of experience supporting more than 200 clinical tr
Bayer Begins Phase I Study on BAY 3670549 in Atrial Fibrillation
01:36pm, Wednesday, 21'st May 2025
The phase I study evaluates BAYRY's investigational GIRK4 inhibitor, BAY 3670549, for the treatment of patients with atrial fibrillation.
Bayer Highlights New Data from Oncology and Women's Health Portfolios at 2025 ASCO Annual Meeting
08:00am, Wednesday, 21'st May 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO)
Dr. Yesmean Wahdan from Bayer Discusses Women's Health Month with YourUpdateTV
10:47am, Monday, 19'th May 2025
May is Women's Health Month – Dr. Yesmean Wahdan Shares Important and Timely Tips to Help Women Prioritize Their Health at Every Life Stage May is Women's Health Month – Dr. Yesmean Wahdan Shares
Bayer Stock Investment Could Pay Off, But It Is Not For The Faint Of Heart
04:01pm, Friday, 16'th May 2025
Bayer A.G.'s stock is very cheap and near multi-year lows, but ongoing declines and uncertain turnaround make it risky for conservative investors. Pharmaceuticals and consumer health divisions are sho
Bayer seeks Roundup settlement, explores Monsanto bankruptcy, WSJ reports
07:05pm, Thursday, 15'th May 2025
Bayer is seeking to resolve lawsuits related to its Roundup weedkiller, while exploring a bankruptcy for its Monsanto unit if the settlement plan fails, the Wall Street Journal reported on Thursday, c
Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy
06:46pm, Thursday, 15'th May 2025
The agricultural giant is preparing to place its U.S. subsidiary Monsanto in bankruptcy if a settlement with tort plaintiffs fails
Bayer US head says FDA chief reassured pharma executives of timely reviews
06:16pm, Thursday, 15'th May 2025
Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry executives that the Food and Drug Administration would meet its targets for revi
Bayer Profit Drops 35%, Launches Overhaul To Counter Generic Pressure
03:26pm, Tuesday, 13'th May 2025
Bayer AG BAYRY reported on Tuesday that the first quarter of 2025 net profit was 1.3 billion euros (around $1.45 billion), down from 2 billion euros a year ago.
Bayer A.G. (BAYZF) Q1 2025 Earnings Call Transcript
12:09pm, Tuesday, 13'th May 2025
Bayer A.G. (OTCPK:BAYZF) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo Santos - President, Crop Science Divi
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Hurts Sales
11:00am, Tuesday, 13'th May 2025
BAYRY's first-quarter earnings beat expectations. Revenues miss estimates, mainly due to lower sales of its products in the Crop Science division.
Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case
09:06am, Tuesday, 13'th May 2025
Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company's request to sharply limit litigation that could run into the billions of
Bayer posts smaller than expected 7.4% drop in quarterly adjusted profit
02:43am, Tuesday, 13'th May 2025
Bayer on Tuesday posted a slower decline in first-quarter adjusted earnings than the market had feared as strong prescription numbers for new drugs offset a drop in its soy and cotton seed business.
